PHI-BIS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHI-BIS
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€462,055
2024 · €515,467-€53,412
Equity
€2.6m
2024 · €2.1m+€462,055
Cash
€10,317
2024 · €7,574+€2,743
Balance sheet total
€6.2m
2024 · €5.3m+€927,292
Largest movements
Assets
- Receivables within one year +€610,295
up €610,295 (+21.8%), from €2.8m to €3.4m
of which Trade receivables: +€523,573
- Stocks and contracts +€434,055
up €434,055 (+42.9%), from €1.0m to €1.4m
- Tangible fixed assets -€80,304
down €80,304 (-5.9%), from €1.4m to €1.3m
of which Land and buildings: -€58,850
Equity and liabilities
- Trade debts +€477,279
up €477,279 (+19.2%), from €2.5m to €3.0m
- Profit (loss) carried forward +€462,055
up €462,055 (+33.0%), from €1.4m to €1.9m
Income statement
- Turnover +€1.1m
up €1.1m (+7.5%), from €15.1m to €16.2m
- Goods and materials +€905,234
up €905,234 (+8.9%), from €10.2m to €11.1m
of which Purchases: +€1.5m
- Services and other goods +€441,210
up €441,210 (+26.7%), from €1.7m to €2.1m
- Staff costs -€181,216
down €181,216 (-7.7%), from €2.3m to €2.2m
- Taxes +€175,256
up €175,256 (+103.1%), from €169,935 to €345,191
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€515,467
Turnover
+€1.1m
Other operating income
-€379
Goods and materials
-€905,234
Services and other goods
-€441,210
Staff costs
+€181,216
Depreciation
+€121,292
Other operating charges
+€753
Other operating items
-€201
Financial income
+€34,316
Financial charges
+€2,085
Taxes
-€175,256
Result 2025
€462,055
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€10,547
Investment
-€7,803
Financing
€0
Cash 2024
€7,574
From operations (derived)
+€10,547
Net result for the year
+€462,055
Depreciation
+€113,263
Stocks and contracts
-€434,055
Receivables within one year
-€610,295
Deferred charges and accrued income
+€14,342
Trade debts
+€477,279
Tax, wage and social debts
-€12,042
Investment (derived)
-€7,803
Investment in fixed assets (net)
-€7,803
Cash 2025
€10,317
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,300,880 | €6,228,171 | +€927,292 | +17.5% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €1,429,879 | €1,324,419 | -€105,460 | -7.4% |
| Intangible fixed assets | 21 | €61,225 | €36,069 | -€25,156 | -41.1% |
| Tangible fixed assets | 22/27 | €1,368,654 | €1,288,350 | -€80,304 | -5.9% |
| Land and buildings | 22 | €1,250,638 | €1,191,787 | -€58,850 | -4.7% |
| Plant, machinery and equipment | 23 | €87,923 | €66,447 | -€21,476 | -24.4% |
| Furniture and vehicles | 24 | €28,287 | €30,115 | +€1,828 | +6.5% |
| Other tangible fixed assets | 26 | €0 | €0 | = | |
| Assets under construction and advance payments | 27 | €1,805 | €0 | -€1,805 | -100.0% |
| Current assets | 29/58 | €3,871,001 | €4,903,752 | +€1.0m | +26.7% |
| Stocks and contracts in progress | 3 | €1,011,753 | €1,445,808 | +€434,055 | +42.9% |
| Stocks | 30/36 | €1,011,753 | €1,445,808 | +€434,055 | +42.9% |
| Goods purchased for resale | 34 | €1,011,753 | €1,445,808 | +€434,055 | +42.9% |
| Amounts receivable within one year | 40/41 | €2,805,479 | €3,415,774 | +€610,295 | +21.8% |
| Trade receivables | 40 | €1,898,371 | €2,421,944 | +€523,573 | +27.6% |
| Other amounts receivable | 41 | €907,108 | €993,831 | +€86,723 | +9.6% |
| Cash at bank and in hand | 54/58 | €7,574 | €10,317 | +€2,743 | +36.2% |
| Deferred charges and accrued income | 490/1 | €46,195 | €31,853 | -€14,342 | -31.0% |
| Total equity and liabilities | 10/49 | €5,300,880 | €6,228,171 | +€927,292 | +17.5% |
| Equity | 10/15 | €2,141,329 | €2,603,384 | +€462,055 | +21.6% |
| Contributions | 10/11 | €700,000 | €700,000 | = | 0.0% |
| Reserves | 13 | €41,763 | €41,763 | = | 0.0% |
| Non-distributable reserves | 130/1 | €26,437 | €26,437 | = | 0.0% |
| Reserves not available under the articles | 1311 | €26,437 | €26,437 | = | 0.0% |
| Distributable reserves | 133 | €15,326 | €15,326 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,399,566 | €1,861,621 | +€462,055 | +33.0% |
| Investment grants | 15 | €0 | - | = | |
| Amounts payable | 17/49 | €3,159,551 | €3,624,787 | +€465,237 | +14.7% |
| Amounts payable within one year | 42/48 | €3,159,551 | €3,624,787 | +€465,237 | +14.7% |
| Trade debts | 44 | €2,488,851 | €2,966,130 | +€477,279 | +19.2% |
| Suppliers | 440/4 | €2,488,851 | €2,966,130 | +€477,279 | +19.2% |
| Taxes, remuneration and social security | 45 | €670,699 | €658,658 | -€12,042 | -1.8% |
| Taxes | 450/3 | €237,678 | €309,602 | +€71,924 | +30.3% |
| Remuneration and social security | 454/9 | €433,022 | €349,056 | -€83,966 | -19.4% |
| Operating income | 70/76A | €15,108,963 | €16,237,588 | +€1.1m | +7.5% |
| Turnover | 70 | €15,063,769 | €16,192,973 | +€1.1m | +7.5% |
| Other operating income | 74 | €44,944 | €44,565 | -€379 | -0.8% |
| Non-recurring operating income | 76A | €251 | €50 | -€201 | -80.0% |
| Operating charges | 60/66A | €14,433,432 | €15,476,613 | +€1.0m | +7.2% |
| Goods for resale, raw materials and consumables | 60 | €10,197,129 | €11,102,363 | +€905,234 | +8.9% |
| Purchases | 600/8 | €10,049,782 | €11,536,418 | +€1.5m | +14.8% |
| Change in stocks: decrease (increase) | 609 | €147,347 | -€434,055 | -€581,402 | |
| Services and other goods | 61 | €1,650,768 | €2,091,978 | +€441,210 | +26.7% |
| Remuneration, social security and pensions | 62 | €2,341,908 | €2,160,692 | -€181,216 | -7.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €234,555 | €113,263 | -€121,292 | -51.7% |
| Other operating charges | 640/8 | €9,071 | €8,317 | -€753 | -8.3% |
| Operating profit (loss) | 9901 | €675,532 | €760,974 | +€85,443 | +12.6% |
| Financial income | 75/76B | €34,811 | €69,127 | +€34,316 | +98.6% |
| Recurring financial income | 75 | €34,811 | €69,127 | +€34,316 | +98.6% |
| Income from current assets | 751 | €33,021 | €68,721 | +€35,700 | +108.1% |
| Other financial income | 752/9 | €1,790 | €406 | -€1,384 | -77.3% |
| Financial charges | 65/66B | €24,940 | €22,856 | -€2,085 | -8.4% |
| Recurring financial charges | 65 | €24,940 | €22,856 | -€2,085 | -8.4% |
| Debt charges | 650 | €18,515 | €15,697 | -€2,818 | -15.2% |
| Other financial charges | 652/9 | €6,425 | €7,158 | +€733 | +11.4% |
| Profit (loss) for the period before taxes | 9903 | €685,403 | €807,246 | +€121,844 | +17.8% |
| Income taxes | 67/77 | €169,935 | €345,191 | +€175,256 | +103.1% |
| Taxes | 670/3 | €169,935 | €345,191 | +€175,256 | +103.1% |
| Profit (loss) for the period | 9904 | €515,467 | €462,055 | -€53,412 | -10.4% |
| Profit (loss) for the period to be appropriated | 9905 | €515,467 | €462,055 | -€53,412 | -10.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.